10-Q: FitLife Brands Reports Q1 2025 Results: Revenue Declines Slightly Amid Brand Performance Shifts

FitLife Brands experienced a slight decrease in revenue for Q1 2025, with shifts in performance across its brand portfolio.

Summary

• FitLife Brands reported a 4% decrease in revenue for the three months ended March 31, 2025, totaling $15.94 million compared to $16.55 million in the same period last year.
• The decrease in revenue is primarily attributed to lower sales from the MRC (Mimi's Rock Corp) brands, partially offset by increased revenue from the Legacy FitLife brands.
• Legacy FitLife revenue increased by 5% to $7.30 million, driven by growth in both online and wholesale channels.
• MRC revenue decreased by 11% to $6.67 million, while MusclePharm revenue decreased by 6% to $1.96 million.
• Online revenue accounted for approximately 67% of total net revenue, compared to 65% in the prior year.
• Gross profit decreased by 6% to $6.87 million, with a gross margin of 43.1% compared to 44.0% in the prior year.
• Advertising and marketing expenses decreased by 14% due to optimization efforts.
• Net income decreased by 7% to $2.02 million, with basic earnings per share of $0.22 and diluted earnings per share of $0.20.
• The company effected a 2-for-1 stock split on February 7, 2025.
• The Board approved a further extension of the Share Repurchase Program on May 13, 2025, authorizing management to repurchase up to $5 million of the company's common stock.

Sentiment

Score: 5

Explanation: The report presents a mixed picture. While there are some positive aspects, such as the growth in Legacy FitLife revenue and the decrease in advertising expenses, the overall decline in revenue and net income suggests a neutral to slightly negative outlook.

Positives

• Legacy FitLife revenue increased by 5%, indicating strength in those brands.
• Online revenue continues to be a significant portion of total revenue, representing 67%.
• Advertising and marketing expenses decreased by 14%, suggesting improved efficiency in marketing spend.
• The company remains in compliance with all covenants of its Amended Credit Agreement.
• The Board approved a further extension of the Share Repurchase Program on May 13, 2025, authorizing management to repurchase up to $5 million of the company's common stock.

Negatives

• Overall revenue decreased by 4%, primarily due to lower sales from MRC and MusclePharm brands.
• MRC revenue decreased by 11%, indicating potential challenges within that brand portfolio.
• Gross margin decreased to 43.1% from 44.0% in the prior year.
• Net income decreased by 7% to $2.02 million.

Risks

• The company's performance is subject to fluctuations in foreign currencies due to the MRC acquisition.
• The company is dependent on cash flow from operations and amounts available under the Line of Credit to satisfy its working capital requirements.
• The company's stock price experiences significant price fluctuations, this will impact the fair value of the reporting unit, which can lead to potential impairment in future periods.
• The company is exposed to interest rate risk related to borrowings under the Amended Credit Agreement and investments in short-term financial instruments.

Future Outlook

The company anticipates that cash derived from operations and existing cash reserves, along with available borrowings under the Line of Credit, will be sufficient to provide for the company's liquidity for the next twelve months.

Industry Context

The nutritional supplements and wellness products industry is competitive and subject to changing consumer preferences and regulatory requirements. FitLife Brands competes with other companies in the industry through various distribution channels, including online retail, wholesale, and franchised stores. The company's performance is influenced by factors such as brand recognition, product innovation, and marketing effectiveness.

Comparison to Industry Standards

• It's difficult to provide a precise comparison to industry standards without specific competitor data, but generally, a gross margin of 43.1% is within a reasonable range for the nutritional supplement industry.
• Companies like Herbalife Nutrition and Nu Skin Enterprises typically operate with gross margins in the 70-80% range, but their business models and product mixes differ significantly from FitLife Brands.
• FitLife's reliance on online sales (67% of revenue) aligns with the broader trend of e-commerce growth in the health and wellness sector.
• The decrease in advertising and marketing expenses suggests a focus on efficiency, which is a common strategy in the face of revenue pressures.
• The company's debt-to-EBITDA ratio is a key metric to watch, as it indicates the company's leverage and ability to service its debt.

Stakeholder Impact

• Shareholders may be concerned about the decrease in revenue and net income.
• Employees may be affected by potential changes in strategy or operations.
• Customers may be impacted by changes in product offerings or pricing.
• Suppliers may be affected by changes in purchasing patterns.
• Creditors will monitor the company's compliance with the Amended Credit Agreement.

Next Steps

• The company will continue to monitor the performance of its brands and adjust its strategies as needed.
• The company will focus on optimizing its advertising spend and improving its gross margins.
• The company will continue to evaluate potential new product launches and partnerships.
• The company will continue to monitor its compliance with the Amended Credit Agreement.
• The company may repurchase shares under the extended Share Repurchase Program.

Key Dates

Keywords

FitLife Brands, revenue, financial results, Q1 2025, MRC, Legacy FitLife, MusclePharm, stock split, share repurchase, nutritional supplements